Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-21-011236
Filing Date
2021-04-01
Accepted
2021-04-01 16:12:29
Documents
8
Period of Report
2021-05-12

Document Format Files

Seq Description Document Type Size
1 DEF14A nc10021629x1_def14a.htm DEF 14A 991360
2 nc10021629x1_img01.jpg GRAPHIC 104749
3 nc10021629x1_img02.jpg GRAPHIC 35740
4 nc10021629x1_img03.jpg GRAPHIC 36215
5 nc10021629x1_img04.jpg GRAPHIC 39211
6 nc10021629x1_img05.jpg GRAPHIC 42936
7 nc10021629x1_img06.jpg GRAPHIC 333986
8 nc10021629x1_img07.jpg GRAPHIC 251353
  Complete submission text file 0001140361-21-011236.txt   2148891
Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Filer) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30739 | Film No.: 21798110
SIC: 2834 Pharmaceutical Preparations